IAG Holdings Limited (HK:8513)
:8513
Top Page
IAG Holdings Limited
(8513)
Select Model
Select Model
Rating:40Underperform
Price Target:
HK$0.64
▲(430.83% Upside)
Action:DowngradedDate:01/15/26
The score is primarily constrained by weak financial performance (declining revenue, negative margins, high leverage, and negative operating/free cash flow). Technicals also remain bearish with the price below major moving averages and a negative MACD, with only a partial offset from oversold RSI. Valuation is not supportive due to loss-making earnings and no dividend yield provided.
Positive Factors
Diversified Business Model
IAG's diversified investment model spans real estate, financial services and technology, creating multiple durable revenue sources (rent, management/performance fees, startup equity). Structural diversification reduces single-sector risk and gives optionality to reallocate capital across cycles.
Negative Factors
Unprofitable Operations
Financial statements indicate declining revenue and negative margins across gross, EBIT/EBITDA and net levels. Persistent unprofitability erodes retained capital, limits self-funding for growth, pressures margins long-term, and heightens the need for structural cost or business-model remediation.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified Business Model
IAG's diversified investment model spans real estate, financial services and technology, creating multiple durable revenue sources (rent, management/performance fees, startup equity). Structural diversification reduces single-sector risk and gives optionality to reallocate capital across cycles.
Read all positive factors
IAG Holdings Limited (8513) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$43.38M
Dividend YieldN/A
Average Volume (3M)1.39M
Price to Earnings (P/E)―
Beta (1Y)-1.05
Revenue Growth47.80%
EPS Growth82.95%
CountryHK
Employees88
SectorHealthcare
Sector Strength45
IndustryMedical - Equipment & Services
Share Statistics
EPS (TTM)-0.03
Shares Outstanding81,845,535
10 Day Avg. Volume3,139,600
30 Day Avg. Volume1,390,533
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)10.75
Price to Sales (P/S)2.20
P/FCF Ratio-18.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IAG Holdings Limited Business Overview & Revenue Model
Company Description
IAG Holdings Limited is an investment holding company mainly engaged in the manufacturing and sale of injection molded plastic parts for disposable medical devices. It also provides tooling services. Molded plastic parts include component parts, a...
How the Company Makes Money
IAG Holdings Limited generates revenue primarily through its diversified investment portfolio. The company earns income from its real estate projects through rental income and property sales. In the financial services sector, IAG Holdings may rece...
IAG Holdings Limited Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.65M | 10.46M | 9.15M | 13.90M | 19.77M | 23.20M |
| Gross Profit | 1.71M | 44.00K | -730.00K | 938.00K | 3.97M | 4.56M |
| EBITDA | -258.50K | -1.35M | -2.40M | -1.76M | -4.63M | 4.33M |
| Net Income | -1.24M | -2.63M | -6.75M | -3.06M | -7.05M | 784.00K |
Balance Sheet | ||||||
| Total Assets | 8.34M | 8.75M | 10.06M | 16.32M | 20.91M | 32.16M |
| Cash, Cash Equivalents and Short-Term Investments | 759.00K | 1.78M | 1.60M | 3.66M | 5.99M | 4.38M |
| Total Debt | 4.05M | 4.20M | 4.24M | 2.59M | 3.52M | 5.11M |
| Total Liabilities | 6.42M | 6.63M | 7.19M | 7.19M | 10.16M | 14.48M |
| Stockholders Equity | 1.94M | 2.14M | 2.88M | 8.65M | 10.10M | 17.17M |
Cash Flow | ||||||
| Free Cash Flow | -1.14M | -1.24M | -1.25M | -1.37M | 2.92M | 2.83M |
| Operating Cash Flow | -1.09M | -986.00K | -1.19M | -582.00K | 3.16M | 3.09M |
| Investing Cash Flow | 64.00K | -145.00K | 3.00K | -751.00K | -365.00K | -163.00K |
| Financing Cash Flow | -210.00K | 1.31M | 509.00K | -474.00K | -3.19M | -2.16M |
IAG Holdings Limited Technical Analysis
Negative
0.12
Price Trends
0.64
Negative
0.91
Negative
1.11
Negative
Market Momentum
-0.03
Positive
30.58
Neutral
14.33
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8513, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.62, below the 50-day MA of 0.64, and below the 200-day MA of 1.11, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 30.58 is Neutral, neither overbought nor oversold. The STOCH value of 14.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8513.
IAG Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$104.80M | 5.39 | 10.73% | 1.89% | 27.91% | 18.87% | |
58 Neutral | HK$68.54M | -6.14 | -7.26% | ― | -34.73% | -4642.86% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$155.00M | -8.14 | -9.95% | ― | 26.06% | 13.23% | |
47 Neutral | HK$589.93M | -7.56 | ― | ― | -8.46% | 45.13% | |
43 Neutral | HK$87.98M | -4.87 | -27.01% | ― | -11.68% | -71.01% | |
40 Underperform | HK$43.38M | -46.36 | -35.75% | ― | 47.80% | 82.95% |
* Healthcare Sector Average
HK:8513
IAG Holdings Limited
0.53
-1.11
-67.68%
HK:0876
Kaisa Health Group Holdings Limited
0.12
0.09
271.87%
HK:1134
Kelfred Holdings Limited
0.30
0.10
48.51%
HK:2211
Universal Health International Group Holding Ltd.
0.61
-0.38
-38.38%
HK:8357
Republic Healthcare Limited
0.14
0.07
98.59%
HK:8372
Grand Brilliance Group Holdings Limited
0.13
0.03
30.61%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.